Why you should do Impurities Analyses Early in Pharmaceutical Research and Discovery? March 26, 2019 Major impurities in a drug… Read more
Category: Impurities
Developing and Validating an HPLC Method
Developing and Validating an HPLC Method February 20, 2019 A host of resources must be harnessed to bring a drug… Read more
Understanding the importance of stress degradation studies
Understanding the Importance of Stress Degradation Studies December 4, 2018 “Frequently time is of the essence. It is necessary to… Read more
Mass Balance – What, When, How?
Mass Balance – What, When, How? July 10, 2018 This “fishbone diagram”, shown by permission from Steven Baertschi (S. W.… Read more
Averica Answers: Can You Capture a 0.01% Impurity?
Averica Answers: Can You Capture a .01% Impurity? Paul Lefebvre September 14, 2016 Averica Answers is a series of short… Read more
Averica Answers – What is Averica’s Approach to Impurity Isolation?
Averica Answers – What is Averica’s Approach to Impurity Isolation? Paul Lefebvre July 22, 2016 Averica Answers is a series… Read more
5 Ways to Prevent Impurity Isolation Scope Creep
May 24, 2016 Contracting tough projects with a CRO always requires active management, but some projects are complex enough that… Read more
5 Keys to Fast Impurity Isolation
August 26, 2015 Sometimes you know a lot about the genesis of pharmaceutical impurities, and in some cases you know… Read more
Looking at Impurity Isolation Early Can Benefit Your Drug Development Process
Looking at Impurity Isolation Early Can Benefit Your Drug Development Process July 18, 2014 Jeffrey Kiplinger, President and Founder of… Read more
Averica Enters into Preferred Provider Agreement with Irix Pharmaceuticals
Averica Enters into Preferred Provider Agreement with Irix Pharmaceuticals February 4, 2014 Averica’s Targeted IsolationTM Approach Results in Rapid Structure Elucidation… Read more